Anne Kathryn Schuckman, MD

Associate Professor of Clinical Urology

Image of Anne Kathryn Schuckman, MD
Is this your profile? Click to edit

Overview

Dr. Anne Schuckman graduated from Stanford University, and completed her medical training at the University of Southern California School of Medicine. She completed her residency training at LAC+USC Medical Center and her fellowship in urologic oncology under Dr. Donald Skinner at USC Norris Comprehensive Cancer Center.

Dr. Schuckman’s areas if interest include testicular cancer, bladder cancer and urinary reconstruction. She performs both open and laparoscopic procedures, including laparoscopic nephrectomy and partial nephrectomy.

Awards

  • American Urological Association: Murphy Scholar, 2006

Publications

  • Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathwayUrol Oncol. 2019 09; 37(9):572. e13-572. e19. . View in PubMed
  • Urinary tract infections following radical cystectomy with enhanced recovery protocol: A prospective studyUrol Oncol. 2020 03; 38(3):75. e9-75. e14. . View in PubMed
  • Association between early postradical cystectomy kidney injury and perioperative outcome in enhanced recovery eraUrol Oncol. 2023 09; 41(9):389. e15-389. e20. . View in PubMed
  • Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United StatesUrol Oncol. 2019 03; 37(3):180. e1-180. e9. . View in PubMed
  • Chronic kidney disease and radical cystectomy for bladder cancer: perioperative and oncologic outcomes in 1,214 patientsUrol Oncol. 2022 08; 40(8):381. e9-381. e16. . View in PubMed
  • Radical cystectomy and urinary diversion outcomes in patients with single vsdouble renal unit: A 2:1 matched-pair analysis. Urol Oncol. 2023 04; 41(4):207. e17-207. e22. . View in PubMed
  • Recurrence patterns in bladder cancer patients with no residual disease (pT0N0) at radical cystectomy: A 20-year experienceUrol Oncol. 2023 02; 41(2):107. e9-107. e14. . View in PubMed
  • Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict responseUrol Oncol. 2021 02; 39(2):133. e1-133. e8. . View in PubMed
  • Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment J Urol. 2024 Jan 24; 101097JU0000000000003846. . View in PubMed
  • Perioperative mortality for radical cystectomy in the modern Era: experience from a tertiary referral center Int Braz J Urol. 2023 May-Jun; 49(3):351-358. . View in PubMed
  • Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis Lancet Oncol. 2023 06; 24(6):669-681. . View in PubMed
  • Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy J Clin Oncol. 2023 06 01; 41(16):3009-3018. . View in PubMed
  • An Assessment Tool to Provide Targeted Feedback to Robotic Surgical Trainees: Development and Validation of the End-To-End Assessment of Suturing Expertise (EASE) Urol Pract. 2022 Nov; 9(6):532-539. . View in PubMed
  • Reply by Authors Urol Pract. 2022 Nov; 9(6):541. . View in PubMed
  • Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases J Urol. 2022 Feb; 207(2):302-313. . View in PubMed
  • Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit BJU Int. 2022 09; 130(3):381-388. . View in PubMed
  • Long-term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder BJU Int. 2022 08; 130(2):200-207. . View in PubMed
  • Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial Eur Urol. 2022 03; 81(3):223-228. . View in PubMed
  • Bladder Recurrence Following Diagnostic Ureteroscopy in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Cancer: Is Ureteral Access Sheath Protective? Urology. 2022 02; 160:142-146.. View in PubMed
  • Reply by Authors J Urol. 2022 02; 207(2):313. . View in PubMed
  • Enhanced recovery after cystectomy in patients with preoperative narcotic use Can Urol Assoc J. 2021 Oct; 15(10):E563-E568. . View in PubMed
  • Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol Int Urol Nephrol. 2021 Sep; 53(9):1827-1833. . View in PubMed
  • Stoma complications and quality of life in patients with Indiana pouch versus appendico/neo-appendico-umbilicostomy urinary diversions World J Urol. 2021 May; 39(5):1521-1529. . View in PubMed
  • Patient Reported Sexual Function Outcomes in Male Patients Following Open Radical Cystoprostatectomy and Urinary Diversion Urology. 2021 11; 157:161-167. . View in PubMed
  • Evaluation of Bowel Function Following Radical Cystectomy and Urinary Diversion Using Two Validated Questionnaires: What Are the Effects on Quality of Life? Urology. 2021 10; 156:279-284.. View in PubMed
  • Predictors of need for catheterisation and urinary retention after radical cystectomy and orthotopic neobladder in male patients BJU Int. 2021 09; 128(3):304-310. . View in PubMed
  • Feasibility and Outcomes of Orthotopic Ileal Neobladder Reconstruction Following Pelvic Irradiation Urology. 2021 02; 148:198-202. . View in PubMed
  • Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial Lancet Oncol. 2021 01; 22(1):107-117. . View in PubMed
  • Internal audit of an enhanced recovery after surgery protocol for radical cystectomy World J Urol. 2020 Dec; 38(12):3131-3137. . View in PubMed
  • Pelvic hemangiopericytoma: A case report and review of the literature Urol Case Rep. 2020 Sep; 32:101247. . View in PubMed
  • An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer BMC Urol. 2020 Feb 11; 20(1):12. . View in PubMed
  • Heterotopic Bone Formation in Clear Cell Renal Cell Carcinoma Urology. 2020 10; 144:13-14. . View in PubMed
  • Chemoradiation for Management of Locally Recurrent or Residual Bladder Cancer: A Case Series and Review of the Literature Clin Genitourin Cancer. 2020 08; 18(4):e473-e477. . View in PubMed
  • Perioperative Outcome of Suprarenal Resection of Vena Cava Without Reconstruction in Urologic Malignancies: A Case Series and Review of the Literature Urology. 2020 08; 142:146-154. . View in PubMed
  • Occult Nodal Metastases in Patients Down-Staged to Nonmuscle Invasive Disease Following Neoadjuvant Chemotherapy Urology. 2020 08; 142:155-160. . View in PubMed
  • National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013 Eur Urol Oncol. 2020 06; 3(3):343-350. . View in PubMed
  • Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy World J Urol. 2019 Sep; 37(9):1851-1855. . View in PubMed
  • Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer Urology. 2019 11; 133:157-163. . View in PubMed
  • Surgical approach as a determinant factor of clinical outcome following radical cystectomy: Does Enhanced Recovery After Surgery (ERAS) level the playing field? Urol Oncol. 2019 10; 37(10):765-773.. View in PubMed
  • Extended hospital stay after radical cystectomy with enhanced recovery protocol Can J Urol. 2019 02; 26(1):9654-9659. . View in PubMed
  • Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments Urol Oncol. 2019 01; 37(1):40-47. . View in PubMed
  • Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer Urol Oncol. 2019 01; 37(1):1-11. . View in PubMed
  • The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol Ther Adv Urol. 2018 Dec; 10(12):393-401. . View in PubMed
  • The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol World J Urol. 2018 Mar; 36(3):401-407. . View in PubMed
  • Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol Eur Urol Focus. 2018 12; 4(6):889-894. . View in PubMed
  • Optimizing Diagnosis of Urothelial Bladder Cancer with Blue Light Cystoscopy via Recognition of False-Positive Lesions Videourology (New Rochelle). 2018; 32(2). . View in PubMed
  • Feasibility of expert and crowd-sourced review of intraoperative video for quality improvement of intracorporeal urinary diversion during robotic radical cystectomy Can Urol Assoc J. 2017 Oct; 11(10):331-336. . View in PubMed
  • Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients Clin Genitourin Cancer. 2017 Sep 06. . View in PubMed
  • Current Management Strategy for Penile Cancer and Future Directions Curr Oncol Rep. 2017 Aug; 19(8):54. . View in PubMed
  • 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study World J Urol. 2017 Jun; 35(6):907-911. . View in PubMed
  • Cost Analysis of the Enhanced Recovery After Surgery Protocol in Patients Undergoing Radical Cystectomy for Bladder Cancer Eur Urol Focus. 2016 Apr; 2(1):92-96. . View in PubMed
  • Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire J Urol. 2016 12; 196(6):1685-1691. . View in PubMed
  • Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile CancerClin Genitourin Cancer. 2016 10; 14(5):450-456. e1. . View in PubMed
  • Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway J Urol. 2015 Nov; 194(5):1209-13. . View in PubMed
  • Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy World J Urol. 2015 Oct; 33(10):1397-402. . View in PubMed
  • Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience Urology. 2015 Jul; 86(1):87-91. . View in PubMed
  • Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events J Urol. 2015 Feb; 193(2):565-9. . View in PubMed
  • Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy Urology. 2014 Dec; 84(6):1420-6. . View in PubMed
  • Significance of perivesical lymph nodes in radical cystectomy for bladder cancer Urol Oncol. 2014 Nov; 32(8):1158-65. . View in PubMed
  • Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA Nat Rev Urol. 2014 Oct; 11(10):589-96. . View in PubMed
  • Level III-IV inferior vena caval thrombectomy without cardiopulmonary bypass: long-term experience with intrapericardial control J Urol. 2014 Sep; 192(3):682-8. . View in PubMed
  • Enhanced recovery protocol after radical cystectomy for bladder cancer J Urol. 2014 Jul; 192(1):50-5. . View in PubMed
  • Clinicopathologic characteristics and outcomes of penile cancer treated at tertiary care centers in the Western United States Clin Genitourin Cancer. 2014 Apr; 12(2):138-42. . View in PubMed
  • Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy Urol Oncol. 2014 Feb; 32(2):110-6. . View in PubMed
  • Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era Urol Oncol. 2014 Feb; 32(2):85-91. . View in PubMed
  • Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases Urology. 2014 Jan; 83(1):159-65. . View in PubMed
  • Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patientsUrol Oncol. 2014 Jan; 32(1):52. e1-9. . View in PubMed
  • The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder PLoS One. 2014; 9(8):e105326. . View in PubMed
  • Neoadjuvant chemotherapy with gemcitabine/cisplatin vsmethotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California. Urol Oncol. 2013 Nov; 31(8):1737-43. . View in PubMed
  • Factors influencing post-recurrence survival in bladder cancer following radical cystectomy BJU Int. 2012 Mar; 109(6):846-54. . View in PubMed
  • Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. 2011 Mar; 107(5):724-728.. View in PubMed
  • Surgical considerations for elderly urologic oncology patients Urol Oncol. 2009 Nov-Dec; 27(6):628-32. . View in PubMed